Literature DB >> 24801890

Loss of Notch1-dependent p21(Waf1/Cip1) expression influences the Notch1 outcome in tumorigenesis.

Samantha Cialfi1, Rocco Palermo2, Sonia Manca1, Carlo De Blasio1, Paula Vargas Romero1, Saula Checquolo3, Diana Bellavia1, Daniela Uccelletti4, Michele Saliola4, Angelo D'Alessandro5, Lello Zolla5, Alberto Gulino6, Isabella Screpanti1, Claudio Talora1.   

Abstract

Notch signaling plays a complex role in carcinogenesis, and its signaling pathway has both tumor-suppressor and oncogenic components. In this study we investigated the effects of reactive oxygen species (ROS) on Notch1 signaling outcome in keratinocyte biology. We demonstrate that Notch1 function contributes to the arsenic-induced keratinocyte transformation. We found that acute exposure to arsenite increases oxidative stress and inhibits proliferation of keratinocyte cells by upregulation of p21(waf1/Cip1). The necessity of p21(waf1/Cip1) for arsenite-induced cell death was demonstrated by targeted downregulation of p21(waf1/Cip1) by using RNA interference. We further demonstrated that on acute exposure to arsenite, p21(waf1/Cip1) is upregulated and Notch1 downmodulated, whereas on chronic exposure to arsenite, malignant progression of arsenite-treated keratinocytes cells was accompanied by regained expression and activity of Notch1. Notch1 activity in arsenite-transformed keratinocytes inhibits arsenite-induced upregulation of p21(waf1/Cip1) by sustaining c-myc expression. We further demonstrated that c-myc collaborates with Nrf2, a key regulator for the maintenance of redox homeostasis, to promote metabolic activities that support cell proliferation and cytoprotection. Therefore, Notch1-mediated repression of p21(waf1/Cip1) expression results in the inhibition of cell death and keratinocytes transformation. Our results not only demonstrate that sustained Notch1 expression is at least one key event implicated in the arsenite human skin carcinogenic effect, but also may provide mechanistic insights into the molecular aspects that determine whether Notch signaling will be either oncogenic or tumor suppressive.

Entities:  

Keywords:  Notch; Nrf2; metabolism; p21

Mesh:

Substances:

Year:  2014        PMID: 24801890      PMCID: PMC4111696          DOI: 10.4161/cc.29079

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  57 in total

Review 1.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

2.  Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells.

Authors:  Marco Mazzone; Laura M Selfors; John Albeck; Michael Overholtzer; Sanja Sale; Danielle L Carroll; Darshan Pandya; Yiling Lu; Gordon B Mills; Jon C Aster; Spyros Artavanis-Tsakonas; Joan S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-01       Impact factor: 11.205

3.  Regulation of notch1 signaling by nrf2: implications for tissue regeneration.

Authors:  Nobunao Wakabayashi; Soona Shin; Stephen L Slocum; Elin S Agoston; Junko Wakabayashi; Mi-Kyoung Kwak; Vikas Misra; Shyam Biswal; Masayuki Yamamoto; Thomas W Kensler
Journal:  Sci Signal       Date:  2010-07-13       Impact factor: 8.192

4.  Activation of the NOTCH pathway in head and neck cancer.

Authors:  Wenyue Sun; Daria A Gaykalova; Michael F Ochs; Elizabeth Mambo; Demetri Arnaoutakis; Yan Liu; Myriam Loyo; Nishant Agrawal; Jason Howard; Ryan Li; Sun Ahn; Elana Fertig; David Sidransky; Jeffery Houghton; Kalyan Buddavarapu; Tiffany Sanford; Ashish Choudhary; Will Darden; Alex Adai; Gary Latham; Justin Bishop; Rajni Sharma; William H Westra; Patrick Hennessey; Christine H Chung; Joseph A Califano
Journal:  Cancer Res       Date:  2013-12-18       Impact factor: 12.701

Review 5.  Oxidative shielding or oxidative stress?

Authors:  Robert K Naviaux
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

6.  Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease.

Authors:  S Cialfi; C Oliviero; S Ceccarelli; C Marchese; L Barbieri; G Biolcati; D Uccelletti; C Palleschi; L Barboni; C De Bernardo; P Grammatico; A Magrelli; M Salvatore; D Taruscio; L Frati; A Gulino; I Screpanti; C Talora
Journal:  Br J Dermatol       Date:  2009-11-09       Impact factor: 9.302

7.  Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands.

Authors:  C Jhappan; D Gallahan; C Stahle; E Chu; G H Smith; G Merlino; R Callahan
Journal:  Genes Dev       Date:  1992-03       Impact factor: 11.361

8.  Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKalpha kinases.

Authors:  Karine Lefort; Anna Mandinova; Paola Ostano; Vihren Kolev; Valerie Calpini; Ingrid Kolfschoten; Vikram Devgan; Jocelyn Lieb; Wassim Raffoul; Daniel Hohl; Victor Neel; Jonathan Garlick; Giovanna Chiorino; G Paolo Dotto
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

9.  Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene.

Authors:  H Uyttendaele; G Marazzi; G Wu; Q Yan; D Sassoon; J Kitajewski
Journal:  Development       Date:  1996-07       Impact factor: 6.868

10.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.

Authors:  W S Pear; J C Aster; M L Scott; R P Hasserjian; B Soffer; J Sklar; D Baltimore
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  9 in total

1.  Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway.

Authors:  Horacio Gonzalez; Carolina Lema; Robert A Kirken; Rosa A Maldonado; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Clin Cancer Drugs       Date:  2015

2.  Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors.

Authors:  Hina Mir; Neeraj Kapur; Rajesh Singh; Guru Sonpavde; James W Lillard; Shailesh Singh
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

3.  Optimization of Protein-Protein Interaction Measurements for Drug Discovery Using AFM Force Spectroscopy.

Authors:  Yongliang Yang; Bixi Zeng; Zhiyong Sun; Amir Monemian Esfahani; Jing Hou; Nian-Dong Jiao; Lianqing Liu; Liangliang Chen; Marc D Basson; Lixin Dong; Ruiguo Yang; Ning Xi
Journal:  IEEE Trans Nanotechnol       Date:  2019-05-14       Impact factor: 2.570

Review 4.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

5.  5FU/Oxaliplatin-Induced Jagged1 Cleavage Counteracts Apoptosis Induction in Colorectal Cancer: A Novel Mechanism of Intrinsic Drug Resistance.

Authors:  Maria Pelullo; Sabrina Zema; Mariangela De Carolis; Samantha Cialfi; Maria Valeria Giuli; Rocco Palermo; Carlo Capalbo; Giuseppe Giannini; Isabella Screpanti; Saula Checquolo; Diana Bellavia
Journal:  Front Oncol       Date:  2022-07-01       Impact factor: 5.738

6.  Notch1 regulates tongue cancer cells proliferation, apoptosis and invasion.

Authors:  Rui-Huan Gan; Hua Wei; Jing Xie; Dan-Ping Zheng; Er-Ling Luo; Xiao-Yu Huang; Jian Xie; Yong Zhao; Lin-Can Ding; Bo-Hua Su; Li-Song Lin; Da-Li Zheng; You-Guang Lu
Journal:  Cell Cycle       Date:  2017-12-21       Impact factor: 4.534

7.  Yeast-Based Screen to Identify Natural Compounds with a Potential Therapeutic Effect in Hailey-Hailey Disease.

Authors:  Graziella Ficociello; Azzurra Zonfrilli; Samantha Cialfi; Claudio Talora; Daniela Uccelletti
Journal:  Int J Mol Sci       Date:  2018-06-20       Impact factor: 5.923

8.  PLK1 targets NOTCH1 during DNA damage and mitotic progression.

Authors:  Carlo De Blasio; Azzurra Zonfrilli; Matteo Franchitto; Germano Mariano; Samantha Cialfi; Nagendra Verma; Saula Checquolo; Diana Bellavia; Rocco Palermo; Dario Benelli; Isabella Screpanti; Claudio Talora
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

9.  TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.

Authors:  Xiquan Ke; Yan Zhao; Xinlan Lu; Zhe Wang; Yuanyuan Liu; Mudan Ren; Guifang Lu; Dan Zhang; Zhenguo Sun; Zhipeng Xu; Jee Hoon Song; Yulan Cheng; Stephen J Meltzer; Shuixiang He
Journal:  Oncotarget       Date:  2015-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.